Key Details
Price
$1.65Annual ROE
353.89%Beta
0.53Events Calendar
Next earnings date:
Apr 1, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 1, 2024Analyst ratings
Recent major analysts updates
Jul 11, 24 Maxim Group
BuySep 28, 23 Maxim Group
HoldMar 31, 23 Maxim Group
BuyFeb 5, 21 Maxim Group
BuyMay 15, 18 HC Wainwright & Co.
BuyMay 15, 18 H.C. Wainwright
BuyAug 17, 17 Maxim Group
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Brainstorm Cell Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Brainstorm Cell Therapeutics?
- Does Brainstorm Cell Therapeutics pay dividends?
- What sector is Brainstorm Cell Therapeutics in?
- What industry is Brainstorm Cell Therapeutics in?
- What country is Brainstorm Cell Therapeutics based in?
- When did Brainstorm Cell Therapeutics go public?
- Is Brainstorm Cell Therapeutics in the S&P 500?
- Is Brainstorm Cell Therapeutics in the NASDAQ 100?
- Is Brainstorm Cell Therapeutics in the Dow Jones?
- When was Brainstorm Cell Therapeutics's last earnings report?
- When does Brainstorm Cell Therapeutics report earnings?
- Should I buy Brainstorm Cell Therapeutics stock now?
What is the ticker symbol for Brainstorm Cell Therapeutics?
The ticker symbol for Brainstorm Cell Therapeutics is NASDAQ:BCLI
Does Brainstorm Cell Therapeutics pay dividends?
No, Brainstorm Cell Therapeutics does not pay dividends
What sector is Brainstorm Cell Therapeutics in?
Brainstorm Cell Therapeutics is in the Healthcare sector
What industry is Brainstorm Cell Therapeutics in?
Brainstorm Cell Therapeutics is in the Biotechnology industry
What country is Brainstorm Cell Therapeutics based in?
Brainstorm Cell Therapeutics is headquartered in United States
When did Brainstorm Cell Therapeutics go public?
Brainstorm Cell Therapeutics's initial public offering (IPO) was on October 7, 2003
Is Brainstorm Cell Therapeutics in the S&P 500?
No, Brainstorm Cell Therapeutics is not included in the S&P 500 index
Is Brainstorm Cell Therapeutics in the NASDAQ 100?
No, Brainstorm Cell Therapeutics is not included in the NASDAQ 100 index
Is Brainstorm Cell Therapeutics in the Dow Jones?
No, Brainstorm Cell Therapeutics is not included in the Dow Jones index
When was Brainstorm Cell Therapeutics's last earnings report?
Brainstorm Cell Therapeutics's most recent earnings report was on Nov 14, 2024
When does Brainstorm Cell Therapeutics report earnings?
The next expected earnings date for Brainstorm Cell Therapeutics is Apr 1, 2025
Should I buy Brainstorm Cell Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions